Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study)

Ulrich, S; Speich, R; Domenighetti, G; Geiser, T; Aubert, JD; Rochat, T; Huber, L; Treder, U; Fischler, M (2007). Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study). Swiss medical weekly, -137(41-42), pp. 573-80. Muttenz: EMH Schweizerischer Ärzteverlag

Full text not available from this repository. (Request a copy)

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology
UniBE Contributor:	Geiser, Thomas (A)
ISSN:	1424-7860
Publisher:	EMH Schweizerischer Ärzteverlag
Language:	English
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:56
Last Modified:	29 Mar 2023 23:33
Web of Science ID:	000250308100002
URI:	https://boris.unibe.ch/id/eprint/23844 (FactScience: 44815)